Global Renal Denervation Market Report: 2012 Edition
Affecting the lives of millions of people across the globe, hypertension is a chronic medical condition which substantially raises the risk of cardiac malfunction, kidney diseases and insulin resistance. However if the condition is tamed by managing the blood pressure, it suppresses the risk of occurrence of adverse events significantly. But, if it is left untreated, increases the risk of mortality from ischemic heart disease and stroke two folds.
Renal artery denervation (RDN), is a novel therapeutic paradigm meant for treating the resistant hypertension. Basically RDN is a catheter-based therapy which employs either radiofrequency or ultrasound energy for tampering the renal arteries sympathetic nerves whose hyperactivity causes treatment-resistant hypertension.
RDN devices and technologies are the most sought after innovations in the field of medical technology as they provide for an approach for managing and controlling the resistant hypertension, something that wasn’t available in the paramedics’ field before.
Developing novel medical devices using technologies which employ high frequency radiations has been a widely accepted trend these days. The companies operating in this field have been manufacturing devices which are used in the diagnosis and treatment of numerous medical conditions like cancer and hypertension. Despite being a technology which principally works using radiations for medical therapy, RDN has been proven minimally invasive and efficient when practiced heedfully.
The ongoing trends in the respective market include Medtronic’s HTN-3 pivotal study, development of novel renal denervation devices, devising of baroreceptor stimulation technology, ongoing clinical trials and techniques to address the existing limitations of the current technologies. The drivers promoting RDN market’s growth incorporate factors like increasing cases of hypertension, increasing expenditure on healthcare, rising adult population worldwide, and increasing global GNI. Although it’s been a new development in the field of paramedics, it has its own share of difficulties and hurdles where situations and elements such as limitations of invasive technology and treatment-resistant hypertension have been posing acute challenges. The leading players dominating RDN market space include Medtronic Inc., Boston Scientific Corp., St. Jude Medical Inc. and Covidien.
This RDN Market report attempts to elicit the rapidly evolving market by scrutinizing the novel technologies, product offerings, top notch industry players and their respective market shares.
Renal artery denervation (RDN), is a novel therapeutic paradigm meant for treating the resistant hypertension. Basically RDN is a catheter-based therapy which employs either radiofrequency or ultrasound energy for tampering the renal arteries sympathetic nerves whose hyperactivity causes treatment-resistant hypertension.
RDN devices and technologies are the most sought after innovations in the field of medical technology as they provide for an approach for managing and controlling the resistant hypertension, something that wasn’t available in the paramedics’ field before.
Developing novel medical devices using technologies which employ high frequency radiations has been a widely accepted trend these days. The companies operating in this field have been manufacturing devices which are used in the diagnosis and treatment of numerous medical conditions like cancer and hypertension. Despite being a technology which principally works using radiations for medical therapy, RDN has been proven minimally invasive and efficient when practiced heedfully.
The ongoing trends in the respective market include Medtronic’s HTN-3 pivotal study, development of novel renal denervation devices, devising of baroreceptor stimulation technology, ongoing clinical trials and techniques to address the existing limitations of the current technologies. The drivers promoting RDN market’s growth incorporate factors like increasing cases of hypertension, increasing expenditure on healthcare, rising adult population worldwide, and increasing global GNI. Although it’s been a new development in the field of paramedics, it has its own share of difficulties and hurdles where situations and elements such as limitations of invasive technology and treatment-resistant hypertension have been posing acute challenges. The leading players dominating RDN market space include Medtronic Inc., Boston Scientific Corp., St. Jude Medical Inc. and Covidien.
This RDN Market report attempts to elicit the rapidly evolving market by scrutinizing the novel technologies, product offerings, top notch industry players and their respective market shares.
1. HYPERTENSION
1.1 Overview
BP Pattern
Essential Hypertension
Treatment Options
1.2 Global Hypertension Market
Market Overview
Procedure Growth
Market Share
1.3 The US Hypertension Market
Hypertension Prevalence
Market Opportunity
1.4 European Hypertension Market
Hypertension Prevalence
Market Opportunity
2. RENAL DENERVATION
2.1 Overview
RDN Device Comparison
RDN Application beyond Hypertension
2.2 Renal Denervation Market
Global Market
Europe
United States
Rest of World
3. RENAL DENERVATION - MARKET DYNAMICS
3.1 Key Trends
3.1.1 Medtronic’s HTN-3 Pivotal Study
3.1.2 Development of Novel Renal Denervation Devices
3.1.3 Devising of Baroreceptor Stimulation Technology
3.1.4 Ongoing Clinical Trials
3.1.5 Addressing the Existing Limitations of the Current Technologies
3.2 Growth Drivers
3.2.1 Increasing Cases of Hypertension
3.2.2 Increasing Expenditure on Healthcare
3.2.3 Rising Adult Population Worldwide
3.2.4 Increasing Global GNI (Gross National Income)
3.3 Challenges
3.3.1 Limitations of Invasive Technology for Treatment
3.3.2 Treatment-resistant Hypertension
4. RENAL DENERVATION - COMPETITIVE LANDSCAPE
Competitive Overview
Renal Denervation Programs
Technology Comparison
5. COMPANY PROFILES
5.1 Medtronic
Business Overview
Financial Overview
Business Strategies
Expanding Market Share/Product Portfolio
Marketing and Distribution Tactics
5.2 St. Jude Medical
Business Overview
Financial Overview
Business Strategies
Innovative Device Fabrication
Portfolio Expansion through Acquisitions
5.3 Boston Scientific
Business Overview
Financial Overview
Business Strategies
Focus on Research & Development
Improving Financial Flexibility
5.4 Covidien
Business Overview
Financial Overview
Business Strategies
Emphasis on Innovation
Focus on Operational Excellence
6. RDN MARKET OUTLOOK
Global Market
Europe
United States
Rest of World
1.1 Overview
BP Pattern
Essential Hypertension
Treatment Options
1.2 Global Hypertension Market
Market Overview
Procedure Growth
Market Share
1.3 The US Hypertension Market
Hypertension Prevalence
Market Opportunity
1.4 European Hypertension Market
Hypertension Prevalence
Market Opportunity
2. RENAL DENERVATION
2.1 Overview
RDN Device Comparison
RDN Application beyond Hypertension
2.2 Renal Denervation Market
Global Market
Europe
United States
Rest of World
3. RENAL DENERVATION - MARKET DYNAMICS
3.1 Key Trends
3.1.1 Medtronic’s HTN-3 Pivotal Study
3.1.2 Development of Novel Renal Denervation Devices
3.1.3 Devising of Baroreceptor Stimulation Technology
3.1.4 Ongoing Clinical Trials
3.1.5 Addressing the Existing Limitations of the Current Technologies
3.2 Growth Drivers
3.2.1 Increasing Cases of Hypertension
3.2.2 Increasing Expenditure on Healthcare
3.2.3 Rising Adult Population Worldwide
3.2.4 Increasing Global GNI (Gross National Income)
3.3 Challenges
3.3.1 Limitations of Invasive Technology for Treatment
3.3.2 Treatment-resistant Hypertension
4. RENAL DENERVATION - COMPETITIVE LANDSCAPE
Competitive Overview
Renal Denervation Programs
Technology Comparison
5. COMPANY PROFILES
5.1 Medtronic
Business Overview
Financial Overview
Business Strategies
Expanding Market Share/Product Portfolio
Marketing and Distribution Tactics
5.2 St. Jude Medical
Business Overview
Financial Overview
Business Strategies
Innovative Device Fabrication
Portfolio Expansion through Acquisitions
5.3 Boston Scientific
Business Overview
Financial Overview
Business Strategies
Focus on Research & Development
Improving Financial Flexibility
5.4 Covidien
Business Overview
Financial Overview
Business Strategies
Emphasis on Innovation
Focus on Operational Excellence
6. RDN MARKET OUTLOOK
Global Market
Europe
United States
Rest of World
LIST OF CHARTS
BP Pattern across various Stages of Hypertension
Global Interventional Hypertension Procedures (2011-2015E)
Hypertension Prevalence in the US (2010-2015E)
Hypertension Prevalence in the Developed Europe (2010-2015E)
RDN Device Comparison – 30-Day BP Change
Worldwide RDN Procedure Share by Region (2011)
Worldwide RDN Revenue Share by Region (2011)
Rising Global Adult Population (2007-2012E)
World Gross National Income (2005-2010)
Medtronic’s Revenue Share by Business Segments (2012)
Medtronic’s Revenue and Net Earnings Analysis (2009-2012)
St. Jude Medical’s Revenue Share by Business Segments (2011)
St. Jude Medical’s Revenue and Net Earnings Analysis (2007-2011)
Boston Scientific’s Revenue Share by Business Segments (2011)
Boston Scientific’s Revenue and Net Income Analysis (2007-2011)
Covidien’s Revenue Share by Business Segments (2011)
Covidien’s Revenues and Net Income Analysis (2007-2011)
Worldwide RDN Procedure Share by Geography (2012E and 2020E)
Worldwide RDN Revenue Share by Geography (2012E and 2020E)
Global RDN Market Growth (2011-2015E)
List of Tables
Classes of Essential Hypertension
Global Interventional Hypertension Market Model
Patients Taking ≥ 5 Hypertension Medications (2010)
U.S. Interventional Hypertension Unit Build (2010-2015E)
Developed Europe Interventional Hypertension Unit Build
Interventional Hypertension Treatment Products in Development
Global Renal Denervation Market (2011)
European Renal Denervation Market (2011)
US Renal Denervation Market (2011)
Rest of the World Renal Denervation Market (2011)
Clinical Trials for Competitive Technologies
Renal Denervation Programs
Renal Denervation Technologies
Renal Denervation Competitive Technologies Under Development
Global RDN Procedures and Revenue Forecast (2012E-2020E)
Europe RDN Procedures and Revenue Forecast (2012E-2020E)
The US RDN Procedures and Revenue Forecast (2012E-2020E)
Japan RDN Procedures and Revenue Forecast (2014E-2020E)
Rest of the World RDN Procedures and Revenue Forecast (2012E-2020E)
BP Pattern across various Stages of Hypertension
Global Interventional Hypertension Procedures (2011-2015E)
Hypertension Prevalence in the US (2010-2015E)
Hypertension Prevalence in the Developed Europe (2010-2015E)
RDN Device Comparison – 30-Day BP Change
Worldwide RDN Procedure Share by Region (2011)
Worldwide RDN Revenue Share by Region (2011)
Rising Global Adult Population (2007-2012E)
World Gross National Income (2005-2010)
Medtronic’s Revenue Share by Business Segments (2012)
Medtronic’s Revenue and Net Earnings Analysis (2009-2012)
St. Jude Medical’s Revenue Share by Business Segments (2011)
St. Jude Medical’s Revenue and Net Earnings Analysis (2007-2011)
Boston Scientific’s Revenue Share by Business Segments (2011)
Boston Scientific’s Revenue and Net Income Analysis (2007-2011)
Covidien’s Revenue Share by Business Segments (2011)
Covidien’s Revenues and Net Income Analysis (2007-2011)
Worldwide RDN Procedure Share by Geography (2012E and 2020E)
Worldwide RDN Revenue Share by Geography (2012E and 2020E)
Global RDN Market Growth (2011-2015E)
List of Tables
Classes of Essential Hypertension
Global Interventional Hypertension Market Model
Patients Taking ≥ 5 Hypertension Medications (2010)
U.S. Interventional Hypertension Unit Build (2010-2015E)
Developed Europe Interventional Hypertension Unit Build
Interventional Hypertension Treatment Products in Development
Global Renal Denervation Market (2011)
European Renal Denervation Market (2011)
US Renal Denervation Market (2011)
Rest of the World Renal Denervation Market (2011)
Clinical Trials for Competitive Technologies
Renal Denervation Programs
Renal Denervation Technologies
Renal Denervation Competitive Technologies Under Development
Global RDN Procedures and Revenue Forecast (2012E-2020E)
Europe RDN Procedures and Revenue Forecast (2012E-2020E)
The US RDN Procedures and Revenue Forecast (2012E-2020E)
Japan RDN Procedures and Revenue Forecast (2014E-2020E)
Rest of the World RDN Procedures and Revenue Forecast (2012E-2020E)
